Together with Asn auxotrophy, associated with ASNS silencing, arginine auxotrophy, which depends on absent expression of argininosuccinate synthase 1 (ASS1), represents another, widely investigated metabolic vulnerability in human cancers. The gene discussed is ASS1; the disease is cancer.